Showing results (1041-1050 of 1,200) with videos related to
Sort By:
Pageof 120
Medicina Intensiva|May 11, 2024
Postintensive care syndrome in patients and family members. Analysis of COVID-19 and non-COVID-19 cohorts, with face-to-face follow-up at three months and one yearCarola Giménez-Esparza Vich, Beatriz Oliver Hurtado, Maria Angeles Relucio Martinez, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 3, 2021
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs-Findings From the BIOCOVID StudySantiago Muñoz-Fernández, Laura Cebrian, Israel John Thuissard, et al.Intensive Care Medicine|April 14, 2025
Staircase strategy, tier-three therapies, and effects on outcome in traumatic brain injured patients: the Triple-T TBI studyEdoardo Picetti, Laura Galarza, Marta Arroyo Diez, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 7, 2026
Effectiveness and safety of daptomycin versus vancomycin in methicillin-resistant Staphylococci left-side infective endocarditis. Results from a nationwide prospective multicenter cohortJorge Calderón-Parra, Tziar Diego-Yagüe, Patricia Muñoz, et al.Journal of Clinical Microbiology|February 3, 2017
European Multicenter Study on Analytical Performance of DxN Veris System HCV AssayPatrick Braun, Rafael Delgado, Monica Drago, et al.The Lancet. Oncology|February 24, 2015
High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trialAlmudena Zapatero, Araceli Guerrero, Xavier Maldonado, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2024
ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER TrialRoss A Soo, Urania Dafni, Ji-Youn Han, et al.Frontiers in Psychiatry|July 19, 2021
Study Protocol-Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive SymptomsLydia Fortea, Aleix Solanes, Edith Pomarol-Clotet, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 7, 2022
Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in SpainFernando de Frutos, Juan Pablo Ochoa, Cristina Gómez-González, et al.The Lancet. Healthy Longevity|September 2, 2023
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort studyCatarina Tristão-Pereira, Valentin Fuster, Belen Oliva, et al.Pageof 120